MoneyWorks4Me

Shilpa Medicare informs about board meeting

07 Aug 2021 Evaluate

Pursuant to the regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Shilpa Medicare has informed that a meeting of the Board of Directors of the company will be held on Saturday, the 14th day of August, 2021, to transact the following items of business: Approval of the Audited Standalone and Consolidated Financial Results of the Company for the First Quarter ended 30th June, 2021.

The above information is a part of company’s filings submitted to BSE.


Shilpa Medicare Share Price

811.00 -10.90 (-1.33%)
17-Aug-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.70
Dr. Reddys Labs. 1195.15
Cipla 1432.35
Lupin 2225.00
Zydus Lifesciences 1144.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: